New research on eltrombopag plus immunosuppressive therapy for severe aplastic anemia in young patients challenges the ...

Severe aplastic anemia (sAA) is a bone marrow failure disorder which is mostly a consequence of immunologically mediated stem cell destruction. Allogeneic bone marrow transplantation (BMT) from a ...

For patients with acquired severe aplastic anemia without a matched sibling donor and not responding to immunosuppressive treatment, bone marrow transplantation from a suitable alternative donor ...

Aplastic anemia develops when the bone marrow is damaged, and it can no longer synthesize enough stem cells. Stem cells are cells that give rise to other blood cells.

Aplastic anemia is a rare disease resulting from diverse immune-mediated, direct, and acquired pathologic processes. Diagnostic and therapeutic advances have improved survival.

Aplastic anaemia can strike anyone, regardless of age or gender, making awareness efforts vital in reaching a broad audience. Common symptoms include fatigue, paleness, frequent infections, and ...

Aplastic anemia can be managed by following a treatment plan and monitoring symptoms. To prevent excessive bleeding, one must avoid high-contact activities and sports like football, hockey, or ...

Eltrombopag increased response rates when added to standard immunosuppressive therapy among patients with transplant-ineligible severe aplastic anemia, according to phase 3 study results published ...

Aplastic anemia is a challenging disorder for the patient as well as the hematologist. Due to its rarity and complexity, there is a lack of public awareness about aplastic anemia.

Q: What is the difference between Aplastic Anemia and Myelodysplastic syndrome (MDS)? A: In AA the person fails to produce adequate number of bone marrow and blood cells but the few that are ...

View list of generic and brand names of drugs used for treatment of Aplastic Anemia. Find more information including dose, side effects of the Aplastic Anemia medicine.